TABLE 4.
Comparisons of Medication Use Components from the Dubois et al. 2014 Study and the Current Study
| 2014 Study Components28 | Current Component (Component Number) | 2014 Study (na = 46) (Nb = 175) % | Current Study (na = 49) (Nb = 847) % | Significancec |
|---|---|---|---|---|
| Quantify medication offsets | Determine if medication costs are offset by reductions in use of other services (3)d | 7 | 16 | ≤ 0.10 |
| Notify care providers when a prescription is filled | Notify a patient’s care providers when prescriptions are filled and dispensed (5)e | 9 | 16 | |
| Educate patients about alternatives/implications when determining the recommended medication care plan | Educate patients on diagnostic and therapeutic alternatives and their implications (7)f | 11 | 31 | ≤ 0.01 |
| Share potential drug-drug/drug-disease/polypharmacy concerns with the care team | Notify all patient care providers of potential drug-drug, drug-disease, and polypharmacy adverse interactions (20)g | 13 | 45 | ≤ 0.01 |
| Capture patient-reported outcomes electronically | Capture patient-reported outcomes in a provider-accessible electronic system (6)d | 15 | 27 | ≤ 0.10 |
| Notify care providers when Rx’s are prescribed | Notify a patient’s care provider when medications are prescribed by another provider (9)g | 20 | 33 | ≤ 0.10 |
| Involve pharmacists in direct patient care | Involve pharmacists directly in patient care (23)h | 22 | 47 | ≤ 0.01 |
| Alert providers of preventive care gaps | Automatically alert providers of gaps in recommended preventive care (26)g | 28 | 55 | ≤ 0.01 |
| Synchronize formularies across different care sites | Synchronize formularies across sites of care (8)g | 35 | 33 | |
| Identify potential drug-drug, drug-disease, and/or polypharmacy concerns | Identify potential adverse interactions across all patient care efforts (30)g | 43 | 65 | ≤ 0.05 |
| Encourage appropriate generic use with formularies | Encourage generic drug use when appropriate (34)i | 50 | 73 | ≤ 0.01 |
| View prescription and medical data in 1 system | Provide physician access to integrated electronic pharmacy and medical data for individual patients at the point of care (33)g | 54 | 71 | ≤ 0.05 |
| Provide pharmacist access to integrated electronic pharmacy and medical data (28)g | 54 | 59 |
an = number of survey respondents.
bN = number of ACOs in the target population.
cSignificant P values are shown.
dDomain = Analytics and evaluation.
eDomain = Discharge planning and transitional care.
fDomain = Patient education.
gDomain = Health information technology.
hDomain = Care teams and clinical protocols.
iDomain = Prescribing practices.